Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy
As the prevalence of obesity continues to rise worldwide, GLP-1 receptor agonists such as Ozempic and Wegovy have gained significant attention from both healthcare professionals and patients seeking clinically proven, non-surgical weight loss solutions
Effects: Targets skin discoloration, freckles, pigmentation, age spots and sun damage by effectively inhibiting melanin production, hence retaining skin translucency and radiance
You may also experience disturbed vision, pins and needles, muscle weakness, and changes in movement
L-carnitine100mg
In cases of type 1 diabetes, the insulin is absent (not produced as the beta cells are destroyed)